A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if adding GLIADEL to the site where the tumor was removed
works as well as just having the tumor removed with radiation treatment done within six weeks
after the surgery to keep the cancer from coming back.